Houssein Safa

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Houssein Safa is an author at The University of Texas MD Anderson Cancer Center specializing in immunotherapy, checkpoint inhibitor therapy, and immune checkpoint inhibitors.

ORCID

Publications per year

2021–2021

Publications

Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma

Cara Haymaker, Daniel H. Johnson, Ravi Murthy et al. · Cancer Discovery · 2021 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation

Chantal Saberian, Noha Abdel‐Wahab, Ala Abudayyeh et al. · Journal for ImmunoTherapy of Cancer · 2021 · 19 citations · Full text

Life Sciences, Hematology, Immunology +17

1–2 of 2